Research and Markets: Global Cervical Cancer Market 2015-2019

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/72w563/global_cervical)
has announced the addition of the “Global
Cervical Cancer Market 2015-2019”
report to their offering.

The report forecasts the global cervical cancer market to grow at a CAGR
of 4.87% over the period 2014-2019.

The report covers the current scenario and the growth prospects of the
global cervical cancer market for the period of 2015-2019. To calculate
the market size, the report considers revenue generated through the
sales of various drugs used in the treatment and prevention of cervical
cancer.

The report has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the Americas, APAC, and
EMEA; it also covers the landscape of the global cervical cancer market
and its growth prospects in the coming years. The report includes a
discussion of the key vendors operating in this market.

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Disease overview

PART 06: Market landscape

PART 07: Market segmentation by application

PART 08: Market segmentation by type of therapy

PART 09: Geographical segmentation

PART 10: Key brand analysis

PART 11: Pipeline portfolio

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

PART 18: Key vendor analysis

Companies Mentioned:

  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Merck
  • Advaxis Immunotherapies
  • Bionor Pharma
  • Dendreon Corporation
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals
  • Otsuka Pharmaceuticals
  • Profectus Biosciences
  • Virometix
  • Zeria Pharmaceuticals

For more information visit http://www.researchandmarkets.com/research/72w563/global_cervical

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cervical
Cancer